Trade-off involved in choosing between methods when extending the follow-up period of a survival trial.

Methods considered: (A), data is combined assuming independent stage-wise increments; (B), patient-wise separation with pre-fixed end of first-stage follow-up; (C), naive patient-wise separation without pre-fixed end of first-stage follow-up; and (D), patient-wise separation using the full-data guaranteed level-α test.